Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma

  • Authors:
    • Akane Takaya
    • Wei‑Xia Peng
    • Kousuke Ishino
    • Mitsuhiro Kudo
    • Tetsushi  Yamamoto
    • Ryuichi Wada
    • Toshiyuki Takeshita
    • Zenya Naito
  • View Affiliations

  • Published online on: January 28, 2015     https://doi.org/10.3892/ijo.2015.2858
  • Pages: 1573-1581
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Epithelial ovarian cancer (EOC) consists of four major subtypes: clear cell carcinoma (CCC), endometrioid adenocarcinoma (EA), mucinous adenocarcinoma (MA) and serous adenocarcinoma (SA). Relative to the other subtypes, the prognosis of CCC is poor due to a high recurrence rate and chemotherapy resistance, but CCC‑specific biomarkers have yet to be identified. With the aim of identifying diagnostic and treatment biomarkers for CCC, we analyzed 96 cases of EOC (32 CCC, 13 EA, 19 MA, 32 SA) using liquid chromatography/mass spectrometry (LC/MS) followed by immunohistochemistry (IHC) and quantitative reverse transcription PCR (RT‑qPCR). Semi‑quantification of protein differences between subtypes showed upregulation of 150 proteins and downregulation of 30 proteins in CCC relative to the other subtypes. Based on hierarchical clustering that revealed a marked distinction in the expression levels of cystatin B (CYTB) and Annexin A4 (ANXA4) in CCC relative to the other subtypes, we focused the study on CYTB and ANXA4 expression in EOCs by IHC, RT‑qPCR and western blot analyses using tissue specimens and cultured cells. As a result, compared to the other subtypes, CCC showed significantly high expression levels of CYTB and ANXA4 in the analyses. To examine the possibility of CYTB and ANXA4 as serum diagnostic biomarkers of CCC, we checked the protein levels in conditioned media and cell lysates using culture cells. Compared with the other subtypes, CCC cell lines showed a significantly higher level of expression of CYTB in both conditioned media and cell lysates, while ANXA4 showed a higher level of expression in cell lysates only. Our results demonstrate that CYTB and ANXA4 overexpression may be related to carcinogenesis and histopathological differentiation of CCC. CYTB may be a secreted protein, and may serve as a potential serum diagnostic biomarker of CCC, while ANXA4 may be useful as an intracellular marker.
View Figures
View References

Related Articles

Journal Cover

April-2015
Volume 46 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Takaya A, Peng WX, Ishino K, Kudo M, Yamamoto T, Wada R, Takeshita T and Naito Z: Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma. Int J Oncol 46: 1573-1581, 2015
APA
Takaya, A., Peng, W., Ishino, K., Kudo, M., Yamamoto, T., Wada, R. ... Naito, Z. (2015). Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma. International Journal of Oncology, 46, 1573-1581. https://doi.org/10.3892/ijo.2015.2858
MLA
Takaya, A., Peng, W., Ishino, K., Kudo, M., Yamamoto, T., Wada, R., Takeshita, T., Naito, Z."Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma". International Journal of Oncology 46.4 (2015): 1573-1581.
Chicago
Takaya, A., Peng, W., Ishino, K., Kudo, M., Yamamoto, T., Wada, R., Takeshita, T., Naito, Z."Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma". International Journal of Oncology 46, no. 4 (2015): 1573-1581. https://doi.org/10.3892/ijo.2015.2858